Initiator Pharma Cash Flow Statement

Financials in millions DKK. Fiscal year is January - December.

Millions DKK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-11.62	-12.93	-22.87	-38.46	-21.06	-8.7
Depreciation & Amortization	-	-	-	-	0.01	0.03
Other Operating Activities	2.89	2.93	0.67	-3.03	-1.64	0.14
Change in Accounts Receivable	0.06	0.06	2.26	13.03	-15.63	0.13
Change in Accounts Payable	-2.13	-2.13	2.3	-4.24	4.22	0.34
Change in Other Net Operating Assets	-3.02	-	-	-	-	-
Operating Cash Flow	-13.83	-12.08	-17.65	-32.7	-34.1	-8.06
Other Investing Activities	-	-	-	-0.02	-	-
Investing Cash Flow	-	-	-	-0.02	-	-
Long-Term Debt Issued	-	-	2.86	-	13.29	-
Net Debt Issued (Repaid)	17.63	-	2.86	-	13.29	-
Issuance of Common Stock	13.01	1.81	0.01	37.48	41.65	13.59
Repurchase of Common Stock	-0.11	-0.69	-	-	-	-
Other Financing Activities	-	-	-	-	-	0.41
Financing Cash Flow	30.53	1.12	2.87	37.48	54.94	14.01
Miscellaneous Cash Flow Adjustments	-0	-0	-	-	-	-
Net Cash Flow	16.7	-10.97	-14.78	4.77	20.84	5.94
Free Cash Flow	-13.83	-12.08	-17.65	-32.7	-34.1	-8.06
Free Cash Flow Per Share	-0.23	-0.21	-0.34	-0.68	-0.97	-0.29
Cash Interest Paid	0.91	0.83	2.41	-	-	-
Cash Income Tax Paid	-	-4.83	-5.5	-3.18	-1.54	-1.69
Levered Free Cash Flow	-10.62	-8.21	-11.72	-21.12	-28.19	-5.14
Unlevered Free Cash Flow	-10.62	-8.21	-11.67	-19.62	-27.45	-5.14
Change in Working Capital	-5.1	-2.08	4.56	8.79	-11.41	0.46

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.